Innate immune activation in neonatal tracheal aspirates suggests endotoxin-driven inflammation

Pediatric Research

Volumn 72, Issue 2, 2012, Pages 203-211

  Nathe, Katheryn E ^a,b,c,d   Mancuso, Christy J ^a   Parad, Richard ^a,b,d   Van Marter, Linda J ^a,b,d   Martin, Camilia R ^d,e   Stoler Barak, Liat ^a   Philbin, Victoria J ^a,d   Phillips, Michele F ^b   Palmer, Christine D ^a,d   Levy, Ofer ^a,d  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALGRANULIN; CALGRANULIN C; ENDOTOXIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INFLAMMASOME; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; SERINE PROTEINASE INHIBITOR; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ARTICLE; ARTIFICIAL VENTILATION; CYTOKINE PRODUCTION; FEMALE; FLOW CYTOMETRY; HUMAN; INNATE IMMUNITY; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL; NEWBORN; NEWBORN CARE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REAL TIME POLYMERASE CHAIN REACTION; RESPIRATORY TRACT INFLAMMATION; TRACHEAL ASPIRATION PROCEDURE;

AGE FACTORS; ANALYSIS OF VARIANCE; CYTOKINES; ENDOTOXINS; FLOW CYTOMETRY; HUMANS; IMMUNITY, INNATE; INFANT, NEWBORN; LIMULUS TEST; MICROSCOPY, FLUORESCENCE; REAL-TIME POLYMERASE CHAIN REACTION; RESPIRATION, ARTIFICIAL; S100 PROTEINS; TRACHEA;

EID: 84864343763     PISSN: 00313998     EISSN: 15300447     Source Type: Journal    
DOI: 10.1038/pr.2012.61     Document Type: Article

References (43)

1. Jobe AH. Antenatal associations with lung maturation and infection. J Perinatol 2005;25:Suppl 2:S31-5. (Pubitemid 40862223)
2. Starner TD, Agerberth B, Gudmundsson GH, McCray PB Jr. Expression and activity of beta-defensins and LL-37 in the developing human lung. J Immunol 2005;174:1608-15.
3. De Dooy J, Ieven M, Stevens W, Schuerwegh A, Mahieu L. Endotracheal colonization at birth is associated with a pathogen-dependent pro-and antiinflammatory cytokine response in ventilated preterm infants: a prospective cohort study. Pediatr Res 2004;56:547-52. (Pubitemid 39280907)
4. De Dooy J, Ieven M, Stevens W, De Clerck L, Mahieu L. High levels of CXCL8 in tracheal aspirate samples taken at birth are associated with adverse respiratory outcome only in preterm infants younger than 28 weeks gestation. Pediatr Pulmonol 2007;42:193-203. (Pubitemid 46417689)
5. Shimotake TK, Izhar FM, Rumilla K, et al. Interleukin (IL)-1 beta in tracheal aspirates from premature infants induces airway epithelial cell IL-8 expression via an NF-kappa B dependent pathway. Pediatr Res 2004;56:907-13. (Pubitemid 39552772)
6. Wynn J, Cornell TT, Wong HR, Shanley TP, Wheeler DS. The host response to sepsis and developmental impact. Pediatrics 2010;125:1031-41.
7. Levy O. Innate immunity of the newborn: basic mechanisms and clinical correlates. Nat Rev Immunol 2007;7:379-90. (Pubitemid 46674489)
8. O'Neill LA. The interleukin-1 receptor/Toll-like receptor superfamily: 10 years of progress. Immunol Rev 2008;226:10-8.
9. Ogura Y, Sutterwala FS, Flavell RA. The inflammasome: first line of the immune response to cell stress. Cell 2006;126:659-62. (Pubitemid 44233635)
10. Wesche H, Henzel WJ, Shillinglaw W, Li S, Cao Z. MyD88: an adapter that recruits IRAK to the IL-1 receptor complex. Immunity 1997;7: 837-47. (Pubitemid 28064897)
11. Palmer CD, Mutch BE, Workman S, McDaid JP, Horwood NJ, Foxwell BM. Bmx tyrosine kinase regulates TLR4-induced IL-6 production in human macrophages independently of p38 MAPK and NFkapp}B activity. Blood 2008;111:1781-8. (Pubitemid 351451482)
12. Severa M, Fitzgerald KA. TLR-mediated activation of type I IFN during antiviral immune responses: fighting the battle to win the war. Curr Top Microbiol Immunol 2007;316:167-92.
13. Poltorak A, Smirnova I, He X, et al. Genetic and physical mapping of the Lps locus: identification of the toll-4 receptor as a candidate gene in the critical region. Blood Cells Mol Dis 1998;24:340-55. (Pubitemid 28524834)
14. Shimazu R, Akashi S, Ogata H, et al. MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. J Exp Med 1999;189:1777-82. (Pubitemid 29272694)
15. Williams LM, Ricchetti G, Sarma U, Smallie T, Foxwell BM. Interleukin-10 suppression of myeloid cell activation-a continuing puzzle. Immunology 2004;113:281-92. (Pubitemid 39472144)
16. Deshmane SL, Kremlev S, Amini S, Sawaya BE. Monocyte chemoattractant protein-1 (MCP-1): an overview. J Interferon Cytokine Res 2009;29:313-26.
17. Kobayashi Y. Neutrophil infiltration and chemokines. Crit Rev Immunol 2006;26:307-16.
18. McDonald JR, Finck BK, McIntosh LM, Wilson SE. Anti-inflammatory approaches that target the chemokine network. Recent Pat Inflamm Allergy Drug Discov 2011;5:1-16.
19. Destin KG, Linden JR, Laforce-Nesbitt SS, Bliss JM. Oxidative burst and phagocytosis of neonatal neutrophils confronting Candida albicans and Candida parapsilosis. Early Hum Dev 2009;85:531-5.
20. Ganz T. Antimicrobial polypeptides in host defense of the respiratory tract. J Clin Invest 2002;109:693-7. (Pubitemid 34263142)
21. Neff SB, Z'graggen BR, Neff TA, et al. Inflammatory response of tracheobronchial epithelial cells to endotoxin. Am J Physiol Lung Cell Mol Physiol 2006;290:L86-96.
22. Ricchetti GA, Williams LM, Foxwell BM. Heme oxygenase 1 expression induced by IL-10 requires STAT-3 and phosphoinositol-3 kinase and is inhibited by lipopolysaccharide. J Leukoc Biol 2004;76:719-26. (Pubitemid 39129106)
23. Ye S, Goldsmith EJ. Serpins and other covalent protease inhibitors. Curr Opin Struct Biol 2001;11:740-5. (Pubitemid 34076636)
24. Nathe KE, Parad R, Van Marter LJ, et al. Endotoxin-directed innate immunity in tracheal aspirates of mechanically ventilated human neonates. Pediatr Res 2009;66:191-6.
25. Bouchon A, Facchetti F, Weigand MA, Colonna M. TREM-1 amplifies inflammation and is a crucial mediator of septic shock. Nature 2001;410:1103-7. (Pubitemid 32391042)
26. Palmer CD, Mancuso CJ, Weiss JP, Serhan CN, Guinan EC, Levy O. 17-Resolvin D1 differentially regulates TLR4-mediated responses of primary human macrophages to purified LPS and live E. coli. J Leukoc Biol 2011;90:459-70.
27. Vogl T, Praper C, Hartmann M, et al. S100A12 is expressed exclusively by granulocytes and acts independently from MRP8 and MRP14. J Biol Chem 1999;274:25291-6.
28. Guignard F, Mauel J, Markert M. Identification and characterization of a novel human neutrophil protein related to the S100 family. Biochem J 1995;309 (Pt 2):395-401.
29. Wittkowski H, Sturrock A, van Zoelen MA, et al. Neutrophil-derived S100A12 in acute lung injury and respiratory distress syndrome. Crit Care Med 2007;35:1369-75. (Pubitemid 46642668)
30. Talwar S, Munson PJ, Barb J, et al. Gene expression profiles of peripheral blood leukocytes after endotoxin challenge in humans. Physiol Genomics 2006;25:203-15.
31. Cole AM, Kim YH, Tahk S, et al. Calcitermin, a novel antimicrobial peptide isolated from human airway secretions. FEBS Lett 2001;504:5-10. (Pubitemid 32777801)
32. Foell D, Wittkowski H, Vogl T, Roth J. S100 proteins expressed in phagocytes: a novel group of damage-associated molecular pattern molecules. J Leukoc Biol 2007;81:28-37. (Pubitemid 46021248)
33. Pietzsch J, Hoppmann S. Human S100A12: a novel key player in inflammation? Amino Acids 2009;36:381-9.
34. Lorenz E, Muhlebach MS, Tessier PA, et al. Different expression ratio of S100A8/A9 and S100A12 in acute and chronic lung diseases. Respir Med 2008;102:567-73.
35. Cayabyab RG, Jones CA, Kwong KY, et al. Interleukin-1beta in the bronchoalveolar lavage fluid of premature neonates: a marker for maternal chorioamnionitis and predictor of adverse neonatal outcome. J Matern Fetal Neonatal Med 2003;14:205-11. (Pubitemid 37186643)
36. Baier RJ, Majid A, Parupia H, Loggins J, Kruger TE. CC chemokine concentrations increase in respiratory distress syndrome and correlate with development of bronchopulmonary dysplasia. Pediatr Pulmonol 2004;37:137-48. (Pubitemid 38120984)
37. Jasson B, Tullus K, Brauner A, Lu Y, Noack G. Early increase of TNF alpha and IL-6 in tracheobronchial aspirate fluid indicator of subsequent chronic lung disease in preterm infants. Arch Dis Child Fetal Neonatal Ed 1997;77:F198-201. (Pubitemid 28201584)
38. Benjamin JT, Carver BJ, Plosa EJ, et al. NF-kappaB activation limits airway branching through inhibition of Sp1-mediated fibroblast growth factor-10 expression. J Immunol 2010;185:4896-903.
39. Guinan EC, Barbon CM, Kalish LA, et al. Bactericidal/permeability- increasing protein (rBPI21) and fluoroquinolone mitigate radiation-induced bone marrow aplasia and death. Sci Transl Med 2011;3:110ra118.
40. Palmer CD, Guinan EC, Levy O. Deficient expression of bactericidal/permeability-increasing protein in immunocompromised hosts: translational potential of replacement therapy. Biochem Soc Trans 2011;39:994-9.
41. Tidswell M, LaRosa SP. Toll-like receptor-4 antagonist eritoran tetrasodium for severe sepsis. Expert Rev Anti Infect Ther 2011;9:507-20.
42. Srivastava A, Casey H, Johnson N, Levy O, Malley R. Recombinant bactericidal/permeability-increasing protein rBPI21 protects against pneumococcal disease. Infect Immun 2007;75:342-9. (Pubitemid 46047910)
43. Bustin SA. Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays. J Mol Endocrinol 2000;25:169-93.